Strategically chosen tachycardia detection and therapy options targeting non-sustained ventricular tachycardia (VT) or ventricular fibrillation (VF) can efficiently reduce the morbidity related to implantable cardioverter defibrillator (ICD) therapy. We report a case of a 60-year-old woman with ischemic cardiomyopathy who underwent ICD implantation due to frequent episodes of non-sustained VT. In this case, the inappropriate setting for VF detection in addition to the limited flexibility in device programming for tachycardia confirmation led to the rapid exhaustion of all available shock therapies.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!